Neximmune Inc

NASDAQ:NEXI 4:00:00 PM EDT

3.41

+0.15 (+4.60%)

4:07:04 PM EDT: $3.20 -0.21 (-6.16%)

Neximmune Inc Stock, NASDAQ:NEXI

9119 Gaither Road, Gaithersburg, Maryland 20877

United States of America

Phone: +1.301.825.9810

Number of Employees: 6

http://www.neximmune.com

Description

NexImmune, Inc. is a clinical stage biotechnology company, which engages in the development of novel approach to immunotherapy designed to employ the body's own T cells to generate an antigen-specific cell-mediated immune response with curative potential for the patient. Its product candidates are NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM. The company was founded by Kenneth C. Carter, Jonathan Schneck, and Mathias Oelke on June 7, 2011 and is headquartered in Gaithersburg, MD.